Dietary fat has been widely studied as a risk factor for breast cancer, with little consistency in results. The Multiethnic Cohort Study (MEC) provides an opportunity to assess this relationship for possible heterogeneity across different racial/ethnic groups, as well as by stratification on several other variables associated with risk. Therefore, we investigated the associations between dietary fat, overall and by type, and breast cancer risk among 85,089 postmenopausal women who entered the MEC by completing a comprehensive dietary questionnaire in 1993-1996.
Introduction
The impact of diet, and particularly dietary fat, on breast cancer risk has been extensively studied (1) . However, the results for dietary fat have been inconsistent and its role in the etiology of breast cancer remains controversial (2, 3) . Several combined analyses have been performed, based on published results or pooled data. Summary estimates for the relative risk indicated a mild increase in the risk of breast cancer related to higher dietary fat in an early meta-analyses of Incident cases of breast cancer were identified by linkage of the cohort to the Surveillance, Epidemiology, and End Results (SEER) cancer registries covering Hawaii and California. Because emigration outside the catchment area has been low (<5%), few incident cases are likely to have been missed. In addition, the cohort was linked to the Hawaii and California state death files and to the National Death Index file. Case and death ascertainment was completed through December 31, 2007. During the average follow-up period of 12.4 years, a total of 3,885 incident invasive cases were identified among the 85,089 postmenopausal women who were available for analysis.
Dietary assessment
Dietary intake was assessed by a self-administered quantitative food frequency questionnaire (QFFQ) with over 180 food items covering the previous year at baseline (12) . The development of the QFFQ has been described (13) , and was based on individual food diaries maintained by a sample of men and women from each ethnic group. It was designed to include the minimum set of foods that contributed ≥ 85% of the intake for nutrients of interest in each ethnic group, as well as foods traditionally consumed by any group regardless of their nutrient contribution. Correlations between the QFFQ and three 24-hour recalls in a calibration study were satisfactory, with a range of 0.42-0.74 across the female ethnic groups for energy-adjusted fat intake; correlations were similar for the various fat components (13) . Individual dietary 6 and those of fatty acids and cholesterol as densities (g or mg/1,000 kcal), since we found in the calibration study that energy-adjusted intakes were better correlated with the reference instrument than were absolute intakes (13) .
Statistical analysis
We used Cox proportional hazards models with age as the time metric to estimate hazard ratio (HR) of breast cancer and 95% confidence intervals (CI) (14, 15) .
All Cox models were adjusted for time since cohort entry (≤2, 2-5, and >5 years) and ethnicity (African American, Native Hawaiian, Japanese, Latina, and white) as strata variables, and age at cohort entry (continuous) as a covariate to account for cohort effect. To ensure that the cohort and period effect were adequately controlled, we compared the results of our models with those using follow-up time as the time metric, with age and year of cohort entry as strata variables, and the results were unchanged. The multivariate models were additionally adjusted for family history of breast cancer (no, yes, missing), education (up to 12 years, more than 12 years, missing), body mass index (BMI: <25, 25-<30, ≥30 kg/m 2 , missing), age at menarche (≤12, 13-14, ≥15 years, missing), age at first live birth (no children, ≤20, 21-30, ≥31 years, missing), number of children for parous women (1, 2-3, ≥4, missing), age at and type of menopause (natural: age <45, 45-<50, 50-<55, ≥55 years; oophorectomy: age <45, 45-<50, ≥50 years; hysterectomy: age <45, 45-<50, ≥50 years; missing), hormone replacement therapy (no current estrogen use, past estrogen use with or without progestin, current estrogen use without progestin, current estrogen use with past/current progestin, missing), smoking status (never, former, current, missing), energy intake (log transformed), and alcohol use at least once a month in the past year (yes, no). Dietary intakes were divided into quintiles based on the distribution of the intake among all women in the cohort. HRs were estimated for the upper four quintiles relative to the lowest quintile. The proportionality assumption was tested by Kaplan-Meier survival curves and Schoenfeld residuals and was found to be valid. A Wald test was used to test trend by entering the sex-and ethnicity-specific median values within the appropriate overall quintile as a continuous variable in the model. We reran the analyses using calibration-corrected intake values for fat variables; these are the predicted levels resulting from applying a calibration equation regressing the average intake from the three 24-hour recalls on QFFQ intake, as well as other important variables such as age, education, and BMI (13).
We conducted analyses separately by estrogen and progesterone receptor (ER/PR) status (ER+/PR+, ER+/PR-, and ER-/PR-cases; there were too few ER-/PR+ cases for meaningful analysis) and by tumor stage (localized and regional/distant cases). Breast cancer cases not counted as events, such as ER-/PR-cases in the analysis of ER+/PR+ tumors, were censored at the age of diagnosis. A Wald test was used to test for heterogeneity across subtypes of cancer using competing risk methodology (16) , where each subtype was a different event. In the competing risk models, we allowed for ethnic-specific effects by ER/PR status or tumor stage to improve the model fit.
We also ran the models stratified by ethnicity (5 groups), BMI (<25, 25-<30, and ≥30 kg/m 8 subgroup membership indicators.SAS version 9.2 (SAS Institute, Inc., Cary, NC) was used for all analyses.
Results
The baseline characteristics of the study population are presented in Table 1 according to total fat intake. Postmenopausal women with higher total fat intake tended to be younger, to be African Americans and Latina, to have less education, to be more obese, and to be younger at menarche and at first live birth, to have more children, to have surgical menopause, to not use hormone replacement therapy, and to consume more energy per day. Table 2 shows the association of fat, overall and by type, with breast cancer. None of the fat intake variables was significantly associated with breast cancer risk in our cohort. Adjusting for all covariates did not make substantial changes to the associations. This was also true when we removed BMI and age at menarche as adjustment factors to avoid adjusting for intermediate variables in the pathway from dietary fat intake and breast cancer risk: the HRs across the quintiles for saturated fat were 1.00, 1.06, 1.10, 1.04, and 0.97 (p for trend=0.60). We also observed no significant association with very low or very high relative fat intake: using a reference of 30.1-35% of energy, the multivariate HR was 0.93 (95% CI, 0.82-1.05) for a fat intake of ≤20% (360 cases) and 0.88 (95% CI, 0.65-1.20) for >45% (44 cases, data not shown).
The same associations were seen in analyses using calibration-corrected intakes: the multivariate HR for the highest vs. lowest quintile was 0.98 (95% CI, 0.87-1.10) for total fat intake and 0.92 (95% CI, 0.82-1.03) for saturated fat intake (data not shown). In an analysis stratified by ethnicity, none of the five ethnic groups showed a significant relationship of dietary fat with postmenopausal breast cancer risk, although the test for heterogeneity across the ethnic groups was statistically significant for eicosapentaenoic acid and docosahexaenoic acid (Table 3) , because of a slight increase in risk among Hawaiians and a slight decrease in risk among Latinas, neither of which were significant. When we examined the associations according to ER/PR status of the tumor, we also observed no significant associations (Table 4 ). Finally, we examined whether the associations varied by tumor stage, BMI, hormone replacement therapy use, follow-up period, family history of breast cancer, and smoking status.
However, none of these factors modified the associations between dietary fat intake and postmenopausal breast cancer (data not shown).
Discussion
In this large multiethnic cohort in Hawaii and California, we found no evidence for an association of dietary fat with breast cancer risk among postmenopausal women. Specific types of dietary fat, including specific fatty acids, were also not related to breast cancer risk.
Furthermore, we found little evidence that the association between dietary fat and postmenopausal breast cancer risk differed by ethnicity, EP/PR status, or tumor stage. This null finding was consistent in additional analyses stratified by BMI, hormone replacement therapy use, follow-up period, family history of breast cancer, and smoking status at baseline.
A substantial body of data is now available from cohort studies to assess the association between dietary fat and breast cancer risk. A meta-analysis of 14 cohort studies reported that the summary relative risk, comparing the highest and lowest levels of intake, was 1.11 (95% CI, (7), in which the raw data from the individual studies were carefully harmonized before being combined, found no evidence of a significant association between dietary fat intake and the risk of breast cancer (relative risk=1.09, 95%
CI=1.00-1.19, per a 5% increment of energy from saturated fat). Also, a recent meta-analysis of 11 cohort studies did not support a positive association between animal fat consumption and breast cancer (17) . More recent findings from large cohort studies have also been inconsistent. In the National Institutes of Health-AARP cohort (11), dietary fat intake was directly associated with risk of postmenopausal breast cancer (HR=1.15; 95% CI, 1.05-1.26, for a twofold increase in total fat intake). The European Prospective Investigation into Cancer and Nutrition (EPIC) Study (10) reported a direct association of borderline statistical significance between saturated fat and breast cancer (HR for the highest vs. the lowest quintile = 1.13; 95% CI, 1.00-1.27). In contrast, the most recent report from the Nurses' Health Study, which had a relatively long follow-up period (20 years) compared to other cohort studies, found no associations between dietary fat and postmenopausal breast cancer (18) . Three cohort studies in Asia suggested a protective effect of long-chain n-3 fatty acids (19) or an increased risk of breast cancer related to a combination of lower n-3 and higher n-6 intake (20, 21) . In the present study, higher n-6/n-3 ratio was not associated with risk in the Asian (Japanese American) group, nor in any of the other ethnic groups.
Only two randomized intervention trials tested the effect of a low-fat diet on breast cancer risk in women with no previous history of this cancer. In the Women's Health Initiative (WHI), the investigators found a non-significant reduction in breast cancer risk among the women in the low-fat intervention arm (22) . Although the intervention group experienced a modest weight loss during the early years of the trial, further analysis showed that weight change did not explain the finding. In the second trial, which tested the effect of a low fat/high carbohydrate diet in women at high risk of breast cancer, there was no weight reduction in the intervention group and the investigators found no effect of the dietary intervention (23) . Two other fat reduction randomized intervention trials were based on patients who had been diagnosed with breast cancer. In the Women's Intervention Nutrition Study (WINS), dietary fat reduction showed a weak, non-statistically significant reduction in relapse-free survival among early-stage postmenopausal breast cancer patients, which was stronger in women with hormone receptor-negative cancers (24) . However, as in the WHI trial, the intervention group also showed a modest weight loss. The second trial in breast cancer patients, known as WHEL (Women's Healthy Eating and Living), tested the effect of a low fat/high vegetable/high fruit/high fiber diet (25) . In this trial, the intervention group did not experience any weight loss, and the results were null. While it is difficult to separate the effects of fat reduction from those resulting from weight loss and/or other simultaneous dietary modifications, there is the additional problem in the trials of breast cancer patients that the effects of fat reduction may be different for recurrence than for initiation of the cancer.
Types of dietary fat, rather than total fat, may be related to the development of breast cancer (26) . A meta-analysis of 3 prospective studies using biomarkers suggested that n-3 fatty acids may have a protective effect, while saturated fatty acids and monounsaturated fatty acids were related to an increased risk of breast cancer (27). In the present study, however, none of subtypes of dietary fat or specific fatty acids showed a significant association with breast cancer.
Findings from both the WINS (24) and the WHI (22) women (27), the investigators also found a suggestion that dietary fat may be associated with ER+/PR+ tumors and not other breast cancer subtypes. However, the Nurses' Health Study found no variation in risk estimates by ER/PR status (18) . In the Multiethnic Cohort, we found that the association of ethnicity and established risk factors and breast cancer risk differed by ER/PR status, which suggests etiologic heterogeneity of hormone receptor-defined subtypes of breast cancer (28). However, the dietary fat-breast cancer relation did not differ across the ER/PR subtypes in the present analysis.
Associations between dietary intake and the risk of breast cancer may vary by menopausal hormone therapy (HT) use, as they do for adiposity and breast cancer risk (29), because HT use is a strong risk factor (30) and may mask the effect of other risk factors on breast cancer development. If dietary fat affects endogenous estrogen levels and subsequently increases risk of breast cancer, this association may be more pronounced among women not using hormone replacement therapy, as was seen in the EPIC Study (10) . However, when we restricted our analysis to women not using hormone replacement therapy, we still found no association between dietary fat and breast cancer (HR for the highest vs. lowest quintile of saturated fat = 0.95; 95% CI, 0.79-1.14, data not shown).
Our study has several strengths, beginning with its large size and prospective design. In addition, dietary exposures to fat have a relatively high variability, mainly due to the multiethnic composition of the population, and have been measured by a validated food frequency questionnaire and a comprehensive food composition table. In addition, however, we were able to examine the association separately by ethnicity. We were also able to control for various risk. Maternal and childhood/adolescence dietary exposures may have an impact on breast cancer risk later in life (31). Unfortunately, we only had dietary information at baseline when the participants were 45 years of age or older. Measurement error in dietary exposures may have reduced our ability to detect associations. However, our previous calibration study showed that adjustment for energy intake using nutrient densities improved the quality of the assessments (13) . Also, analyzing the data using calibration-adjusted values did not change the results.
However, we recognized that the calibration equations were not based on a perfect gold standard, but, rather, on 24-hour recalls which have been found to have correlated errors with QFFQs (32).
Nevertheless, based on our relative risks being so close to the null, it is very unlikely that measurement error would explain our findings. For instance, if the true relative risk for the 5 th quintile for total fat was 1.10 (similar to that in the meta-analysis of 14 cohort studies), simulation studies show that the attenuation factor would have to be less than 0.05 to obtain our observed results with a relative risk of 0.98 in the 5 th quintile. This attenuation factor is much less than those found in the OPEN study for absolute protein (0.14-0.16) and especially for percent of energy from protein (0.32-0.40) (33), and there is no rationale for believing that the MEC QFFQ would perform more poorly than other QFFQs. To further test the influence of measurement error, we also conducted a sensitivity analysis using a small subset of 30 individuals on whom we had serum cholesterol measurements, plus 24-hour recalls and food frequency data. Using the method of triads (34), we found that the effect was further deattenuated, but with little evidence of a relative risk in the range that would be conidered important. Based on this evidence, it is unlikely that moderate or large effects of dietary fat on breast cancer risk would have been missed in our study.
Cancer Research. In conclusion, this prospective study in the Multiethnic Cohort does not support a role of adult intake of dietary fat in the etiology of postmenopausal breast cancer.
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